Company / EPS (Basic)
Dyne Therapeutics, Inc. EPS (Basic) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$3.37
FY2024
5-year range
-$3.95 / -$2.93
FY2021-FY2024
Trend
+14.7%
vs FY2023
Sector context
#157 of 208
Health Care
What the data says
Dyne Therapeutics, Inc.'s eps (basic) of $-3.37 is lower than 75% of companies in the Health Care sector (FY2024). EPS (Basic) returned to growth in FY2024 after 2 years of decline, reaching $-3.37.
Based on SEC 10-K filings.
-3.37 in FY2024.
Declined from $-3.23 to $-3.37 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 208This company -$3.37 Sector average -$1.02
▼
-231.6% below sector average
Key checks
Key Insights
- In FY2024, eps (basic) increased 14.7% year-over-year.
- Ranks #157 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$3.37 | +14.7% |
| FY2023 | -$3.95 | -22.3% |
| FY2022 | -$3.23 | -10.2% |
| FY2021 | -$2.93 | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026